Conteltinib is a small molecule tyrosine kinase inhibitor under investigation in clinical trials. It is a pharmaceutical raw material used in research for advanced solid tumors with specific genetic mutations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1384860-29-0
4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexan-1-ol--hydrogen chloride (1/1)
pharmaceutical raw material
Dexlansoprazole
pharmaceutical raw material
4-Amino-2-methyl-10H-thiene[2,3-b][1,5]benzodiazepine hydrochloride
pharmaceutical raw material
Icatibant acetate
pharmaceutical raw material
2-[[2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-N-propan-2-ylbenzenesulfonamide
NPJCURIANJMFEO-UHFFFAOYSA-N
CC(C)NS(=O)(=O)C1=CC=CC=C1NC2=NC(=NC3=C2CCN3)NC4=C(C=C(C=C4)N5CCC(CC5)N6CCN(CC6)C)OC